# The GATE Study: Endoscopic Sutured Gastroplasty in Type 2 Diabetic, Obese Patients Using the Endomina Device

> **NCT05599477** · PHASE2 · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Diabete Type 2
- Obesity

## Interventions

- **DEVICE:** Endoscopic sutured gastroplasty with endomina

## Key facts

- **NCT ID:** NCT05599477
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05599477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05599477, "The GATE Study: Endoscopic Sutured Gastroplasty in Type 2 Diabetic, Obese Patients Using the Endomina Device". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05599477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*